The day after Christmas, the New York Times published a column by Judith Warner in which she discusses the ethics of using cognition-enhancing drugs beyond the boundaries of their prescriptions. The drugs in question – Ritalin, Adderall and Provigil – are prescribed for attention-deficit disorder (the first two) or narcolepsy (the third). People unafflicted, however, […]